KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Travere Therapeutics (TVTX) Loans and Notes Receivables: 2015-2017

Historic Loans and Notes Receivables for Travere Therapeutics (TVTX) over the last 1 years, with Mar 2017 value amounting to $47.2 million.

  • Travere Therapeutics' Loans and Notes Receivables changed negligibly% to $47.2 million in Q1 2017 from the same period last year, while for Mar 2017 it was $47.2 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $46.8 million for FY2016, which is negligibly% changed negligibly from last year.
  • According to the latest figures from Q1 2017, Travere Therapeutics' Loans and Notes Receivables is $47.2 million, which was up 0.69% from $46.8 million recorded in Q4 2016.
  • Over the past 5 years, Travere Therapeutics' Loans and Notes Receivables peaked at $47.5 million during Q2 2016, and registered a low of $46.5 million during Q3 2015.
  • Moreover, its 3-year median value for Loans and Notes Receivables was $46.8 million (2016), whereas its average is $46.9 million.